BVF-18340-79250
3 vaccinations
6 coded responses
34 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 294 / SC
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
-
2020-12-23
Survey response — days 1–6 daily, dose 1MedDRA: Postpartum state — Feeling: Good · HeadacheFree text: 3 weeks postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-25
Survey response — days 1–6 daily, dose 1MedDRA: Postpartum state — Feeling: Good · HeadacheFree text: 3 weeks post partumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-26
Survey response — days 1–6 daily, dose 1MedDRA: Postpartum state — Feeling: Fair · Fatigue or tirednessFree text: 3 weeks postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-27
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: Postpartum state — Feeling: Fair · HeadacheFree text: 4 weeks postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-29
Survey response — day 7, dose 1MedDRA: Postpartum state — Feeling: Good · HeadacheFree text: 4 weeks postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Postpartum state — Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: 6 weeks postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-21
- 2021-01-27
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-23
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2022-01-01
- 2022-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): 3 weeks postpartum
Systemic reaction (other): 3 weeks post partum
Systemic reaction (other): 3 weeks postpartum
Systemic reaction (other): 4 weeks postpartum
Release 1 — day 7, dose 1
Systemic reaction (other): 4 weeks postpartum
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): 6 weeks postpartum
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Postpartum state | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release